₹1,490.10
+₹3.80 (+0.26%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹3,679 Cr
P/E
37.63
ROE
11.39%
ROCE
15.94%
About Novartis India Ltd
Novartis India is primarily engaged in the business of trading of Pharmaceuticals.
Founded
1947
CEO
C Snook
Employees
61
HQ
Mumbai, India
About Novartis India Ltd
Novartis India is primarily engaged in the business of trading of Pharmaceuticals.
Founded:1947
CEO:C Snook
Employees:61
HQ:Mumbai, India
Finished Products
1Sale of Products
₹1,465.11Cr2Trade Discounts
₹31.77Cr3Other Operating Revenues
₹10.67Cr4Service Income
₹3.50CrRaw Materials
1Purchases
₹588.39CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹1,780
52W Low
₹950
Volume7.17K
Avg VolumeN/A
Beta0.17
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
37.63x
Valuation
P/B Ratio
4.50x
Valuation
EPS
₹39.60
Valuation
Dividend Yield
0.00%
Valuation
ROE
11.39%
Profitability
ROCE
15.94%
Profitability
Revenue by Segment
Contribution & growth by business line
Pharmaceutical BusinessRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
98.8%
International
1.2%
India98.8%
Other Countries1.2%
Strategic Relations
Collaborations, joint ventures & subsidiaries
N
Novartis A G
Switzerland
51.00% stakeForensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.00x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
-1.9%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.